Breast Cancer Invasive Clinical Trials in Shanghai
2 recruitingShanghai, China
Showing 1–2 of 2 trials
Recruiting
Phase 3
Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer
Breast Cancer Invasive
RenJi Hospital488 enrolled1 locationNCT05910398
Recruiting
GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer
Breast Cancer Invasive
Shanghai Jiao Tong University School of Medicine50 enrolled1 locationNCT06725940